Airway 'Resistotypes' and Clinical Outcomes in Bronchiectasis.
Micheál Mac AogáinFransiskus Xaverius IvanTavleen K JaggiHollian RichardsonAmelia ShoemarkJayanth Kumar NarayanaAlison J DickerMariko Siyue KohKen Cheah Hooi LeeOng Thun HowMau Ern PohKa Kiat ChinAlbert Lim Yick HouPuah Ser HonTeck Boon LowJohn Arputhan AbisheganadenKaterina DimakouAntonia DigalakiChrysavgi KostiAnna GkousiouPhilip M HansbroFrancesco BlasiStefano AlibertiJames D ChalmersSanjay Haresh ChotirmallPublished in: American journal of respiratory and critical care medicine (2024)
The bronchiectasis resistome associates with clinical outcomes, geographic origin, and the underlying host microbiome. Bronchiectasis 'resistotypes' link to clinical disease and are modifiable through targeted antimicrobial therapy. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).